New mineralocorticoid receptor antagonists: update on their use in chronic kidney disease and heart failure
Author:
Publisher
Springer Science and Business Media LLC
Subject
Nephrology
Link
http://link.springer.com/content/pdf/10.1007/s40620-019-00600-7.pdf
Reference56 articles.
1. Funder JW (2005) Mineralocorticoid receptors: distribution and activation. Heart Fail Rev 10(1):15–22. https://doi.org/10.1007/s10741-005-2344-2
2. Funder JW (2005) Mineralocorticoid-receptor blockade, hypertension and heart failure. Nat Clin Pract Endocrinol Metab 1(1):4–5. https://doi.org/10.1038/ncpendmet0016
3. Funder JW (2010) Minireview: aldosterone and mineralocorticoid receptors: past, present, and future. Endocrinology 151(11):5098–5102. https://doi.org/10.1210/en.2010-0465
4. Vashistha V, Lee M, Wu YL, Kaur S, Ovbiagele B (2016) Low glomerular filtration rate and risk of myocardial infarction: a systematic review and meta-analysis. Int J Cardiol 223:401–409 https://doi.org/10.1016/j.ijcard.2016.07.175
5. Bansal N, Hsu CY, Go AS (2014) Intersection of cardiovascular disease and kidney disease: atrial fibrillation. Curr Opin Nephrol Hypertens 23(3):275–282. https://doi.org/10.1097/01.mnh.0000444820.80249.56
Cited by 53 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Gene expression analysis to identify mechanisms underlying improvement of myocardial fibrosis by finerenone in SHR;Biochemical Pharmacology;2024-02
2. Single-cell transcriptomics and chromatin accessibility profiling elucidate the kidney-protective mechanism of mineralocorticoid receptor antagonists;Journal of Clinical Investigation;2024-01-02
3. New possibilities of nephroprotection in type 2 diabetes using finerenone Consensus of the board of experts;Diabetes Obesity Metabolic Syndrome;2023-10-27
4. Population pharmacokinetics of esaxerenone, a novel non-steroidal mineralocorticoid receptor blocker, in patients with essential hypertension, patients with diabetic nephropathy, and healthy volunteers;Drug Metabolism and Pharmacokinetics;2023-10
5. T-Cell Mineralocorticoid Receptor Deficiency Attenuates Pathologic Ventricular Remodelling After Myocardial Infarction;Canadian Journal of Cardiology;2023-05
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3